Stress echo: a historical and socio-economic perspective 2, [5] [6] [7] [8] [9] [10] Tennant and Wiggers demonstrated in 1935 that coronary occlusion immediately resulted in instantaneous abnormality of wall motion. A large body of evidence recognized for the first time that transient dyssynergy was an early, sensitive, specific marker of transient ischaemia, clearly more accurate than ECG changes and pain. In European clinical practice, stress echo has been embedded in the legal and cultural framework of existing European laws and medical imaging referral guidelines. 6, 7 The radiation used for medical examinations and tests is the greatest man made source of radiation exposure. Small individual risks of each test performed with ionizing radiation multiplied by a billion examinations become significant population risks. For this reason, in Europe, both the law and the referral guidelines for medical imaging recommend a justified, optimized, and responsible use of testing with ionizing radiation. European Commission referral guidelines were released in 2001 in application of the Euratom Directive, and explicitly state that a non-ionizing technique must be used whenever it will give information grossly comparable with an ionizing investigation. For instance, 'because MRI does not use ionizing radiation, MRI should be preferred when both CT and MRI would provide similar information and when both are available'. In this perspective of the medical, as well as socio-economic and biological impact of medical imaging, it is imperative to increase all efforts to improve appropriateness 8 and minimize the radiation burden of stress imaging for the population and the individual patient. The imperative of sustainability of medical imaging is likely to become increasingly important in the near future, also from a US perspective. In the quest for sustainability, stress echocardiography has unsurpassed assets of low cost, absence of environmental impact, and lack of biological effects for both the patient and the operator compared with equally accurate, but less sustainable, competing techniques. 1, 9, 10 Native Valve Disease The clinical indications for SE in native valve disease can be classified into three categories: severe valve disease without symptoms, non-severe valve disease with symptoms, and valve disease with low flow. In all cases, the purpose of the test is to identify the patients in need of intervention, namely those patients with severe valve disease and symptoms, LV systolic dysfunction, or other haemodynamic consequences. Therefore, in severe valve disease without symptoms the main aim of the test is to elicit symptoms, which may not be otherwise appreciated because of sedentary lifestyle. Additionally, the haemodynamic consequences of exertion in the patient with severe valve disease, such as exercise-induced hypotension or arrhythmia, may be uncovered. In non-severe valve disease with symptoms, the main aim of the test is to question whether the valve disease is actually severe, re-grading the severity based on stress-induced changes or a potential dynamic component. In valve disease with low flow, the aim of the test is to determine whether the valve disease is severe based on flow-dependent changes in severity parameters with stress. [19] [20] [21] [22] [23] Mitral Regurgitation 4 The severity of MR can have a dynamic nature, being load dependent or increasing with exercise. Increase in severity during exertion has been reported regardless of etiology. [24] [25] [26] [27] [28] [29] Images should be acquired at baseline and immediately post-exercise when using a treadmill, and at baseline, low workload, and peak exercise when using a supine bicycle. Dobutamine should not be used instead of exercise to assess the dynamic behaviour of MR because its effects on MR severity are not physiologic. One exception to this is when inducible ischaemia is suspected in a patient who cannot complete an exercise test, as ischaemia may be the mechanism of MR. 19 
Primary MR
In patients with primary MR, exercise echocardiography may provoke symptoms and be useful to assess the SPAP response and stratify risk. 22, 23 Although there is less evidence, the test is also reasonable in symptomatic patients with at least moderate MR. The increase in MR severity (≥1 grade),dynamic PH (SPAP ≥ 60 mmHg), the absence of contractile reserve (<5% increase in EF or <2% increment in global longitudinal strain), and a limited RV contractile recruitment (quantified by tricuspid annular plane systolic excursion (TAPSE) <18 mm)are all parameters of poor prognosis. The lack of contractile reserve predicts decrease in LVEF and symptoms at follow-up in medically managed patients; it also predicts post-operative LV systolic dysfunction in surgically treated patients. 4, [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] When MR is not severe at rest, the dataset should include colour flow Doppler (to allow off-line quantification of severity by PISA method and vena contracta of the regurgitant jet), MR CW Doppler for quantification of severity by PISA method, TR CW Doppler for estimation of the SPAP, and LV views for global and regional systolic function assessment. Image acquisition should be performed in this order as MR severity and SPAP may decrease immediately on termination of the test. The assessment of MR severity parameters becomes more difficult at heart rates >115 bpm. It is important to scan for TR jet velocity by CW Doppler ideally early during exercise since early increase in SPAP is 
Aortic Regurgitation
In severe aortic regurgitation (AR), the onset of symptoms heralds a dramatic change in prognosis, with mortality being reported as high as 10-20% per year. Exercise testing is recommended to reveal symptoms in the patient with severe AR who reports being asymptomatic. 23 Neither exercise nor dobutamine SE can be used to re-grade AR severity in the patient with symptoms, because the test-induced increase in heart rate shortens diastole, limiting quantification of AR severity 4 .
Severe Aortic Regurgitation without Symptoms
Exercise testing is recommended to reveal symptoms. 22 Exercise echocardiography can serve this purpose, concomitantly providing LV contractile reserve assessment, but there is limited evidence to support this indication. The lack of contractile reserve (<5% change in LVEF) was found to predict LV systolic dysfunction development at follow-up or post-operatively.
Rest and exercise longitudinal function assessment (by TDI parameters) may reveal early signs of LV systolic dysfunction. 4,49
Non-severe Aortic Regurgitation with Symptoms
Exercise testing is recommended to confirm equivocal symptoms. 23 Exercise SE can reveal another cause for symptoms (e.g. diastolic dysfunction, PH, or dynamic MR) but evidence in support of this indication is lacking.
Exercise SE rather than pharmacological SE is recommended for assessment of symptoms. Supine bicycle exercise is most appropriate for the assessment of contractile reserve, because images can be acquired at both low and high workloads.
Images should be acquired at baseline and immediately post-exercise when using a treadmill, and at baseline, low workload, and peak exercise when using a supine bicycle. For both indications, the minimum acquired dataset comprises LV views, TR CW Doppler for estimation of SPAP, and color flow Doppler to detect MR, obtained in this order. The sequence of image acquisition always depends on the relative importance of the available information and the likelihood of the persistence of abnormalities into recovery. 4, 19 Impact on Treatment ESC/EACTS and AHA/ACC guidelines consider aortic valve replacement (AVR) class I indication, level of evidence B, in patients with severe AR and symptoms revealed by exercise testing. 42, 43 Mitral Stenosis In mitral stenosis (MS), SE demonstrates the haemodynamic significance of the disease, which can contrast with its anatomically defined severity based on valve area. This could be explained by the indexed valve area being low for the patient or by valve noncompliance to the increase in flow during stress. SE is recommended for the assessment of patients with both severe asymptomatic disease and nonsevere disease with symptoms 22,23 based on extensive evidence. [50] [51] [52] [53] [54] [55] Severe Mitral Stenosis without Symptoms MS is defined as severe when the valve area is <1 cm 2 in the ESC/EACTS guidelines 22 or when the valve area is <1.5 cm 2 in the ACC/AHA guidelines. 22 This difference has little implication for management because, when the valve area is <1.5 cm 2 , the guidelines recommend consideration of the suitability of the valve for balloon valvotomy. Exercise testing is indicated to reveal symptoms when the valve area is <1 cm 2 . 22, 23 If the valve is suitable for balloon valvotomy, SE is indicated to reveal symptoms and assess haemodynamic consequences when the valve area is <1.5 cm 2 but >1 cm 2 . 23, 55 Regardless of suitability for balloon valvotomy, when the valve area is1.5 cm 2 but >1 cm 2 , SE is indicated when planning pregnancy or major surgery. 22, 23 Non-severe Mitral Stenosis with Symptoms SE is indicated to assess the haemodynamic significance of MS, which if severe, may account for symptoms. 50, 56 MS is diagnosed as severe if the mean gradient is >15 mmHg on exertion or >18 mmHg during dobutamine infusion. 52, 53 An SPAP is >60 mmHg on exertion is another marker of haemodynamically significant MS.
Exercise echo provides concomitant mitral valve gradient and SPAP assessment. Early increase in SPAP, at low-level exercise, should be looked for since it is correlated with higher rate of exercise-induced symptoms in asymptomatic patients with mitral valve area d"1.5 cm 2 . 52 Dobutamine SE can be used to assess mitral valve gradients during stress if the patient cannot exercise, but it is not recommended for assessment of SPAP.
Images should be acquired at baseline and immediately post-exercise when using a treadmill; at baseline, low dose and peak when using dobutamine; and at baseline, low workload and peak when using supine bicycle exercise. The minimum acquired dataset comprises TR CW 23 exercise SE has been shown to provide incremental prognostic value beyond exercise testing alone. 58, 59 Images should be acquired at baseline and immediately post-exercise when using a treadmill or at low and peak workload when using supine bicycle exercise. The minimum acquired dataset includes aortic valve CW Doppler for measurement of peak aortic velocity and mean gradient, acquisition of apical four-and twochamber views for the assessment of LVEF by biplane Simpson, then TR CW Doppler for estimation of SPAP . Continuous wave Doppler should ideally be performed from the window from which the maximum velocity was obtained at rest. 4 An increase in mean aortic pressure gradient by e"18-20 mmHg , 58, 59 the absence or limitation of LV functional reserve (decrease or no change in LVEF suggesting subclinical LV dysfunction), 57, 60 and induced PH (SPAP > 60 mmHg) 61 during exercise are markers of poor prognosis.
The increase in mean gradient may reflect either the presence of more severe AS or a noncompliant rigid aortic valve. 58, 59 The lack of LV functional reserve with exercise may reflect more advanced disease with LV afterload mismatch and/or exhaustion of coronary flow reserve with exercise. LVEF lacks sensitivity to detect subclinical LV systolic dysfunction and assessment of longitudinal LV strain seems to be a more powerful parameter in predicting the occurrence of symptoms, exercise intolerance, and cardiac events in asymptomatic AS patients with preserved LVEF. 62 Further studies are needed to determine the best cut-point value of exercise-induced change in LVEF or global longitudinal strain to identify patients at increased risk of developing symptoms, LV systolic dysfunction, or cardiac events. 4 
Impact on Treatment
The increase in mean gradient may be considered an indication for early elective AVR (Class IIb recommendation, level of evidence C in ESC/EACTS guidelines) in asymptomatic patients with severe AS. 22 Patients with severe AS developing PH or with limited contractile reserve and those with moderate AS having a marked increase in pressure gradient during exercise should probably have closer clinical and echocardiographic follow-up. [58] [59] [60] [61] [62] Low-flow, Low-gradient AS Low-flow, low-gradient (LF-LG) AS may occur with depressed (i.e. classical LF-LG) or preserved (i.e. paradoxical LF-LG) LVEF. 63 In both cases, the decrease in gradient relative to AS severity is due to a reduction in transvalvular flow. The main challenge in LF-LG AS is to distinguish between patients with true-severe AS and thus usually benefiting from surgical or transcatheter AVR, vs. patients with pseudo-severe AS who may not necessarily benefit from this intervention. Furthermore, patients with LF-LG severe AS have poor outcomes with conservative management but increased operative risk with surgical AVR. [63] [64] [65] [66] [67] [68] [69] Low-flow, Low-gradient AS with Reduced LV Ejection Fraction Classical LF-LG AS is defined as an aortic valve area (AVA) <1.0 cm 2 , a mean gradient <40 mmHg and an LVEF < 50%. 42, 43 Low-dose dobutamine SE is useful in these patients to assess stenosis severity and LV functional reserve. 64 Fig .- After acquisition at rest, Doppler tracings and LV images are obtained at each dobutamine infusion stage ; the dose increment is delayed until all recordings are considered optimal. The minimum acquired dataset comprises: aortic valve CW Doppler, LVOT PW Doppler (sample volume should be placed as much as possible at the same position in the LVOT during test), views of LV cavity in parasternal long-axis, and apical two-and four-chamber. The imaging assessment includes LV function (changes in EF or global strain) and flow reserve (increase in stroke volume ≥20%), changes in pressure gradients, and AVA. In contrast to the stroke volume, the mean transvalvular flow rate (i.e. stroke volume/LV ejection time), which is, besides the AVA, the main physiological determinant of the increase in gradient, continues to increase at higher doses of dobutamine due to increase in heart rate. 64 For this reason, stopping the test when heart rate increases by e"10 bpm, as proposed by some, may preclude significant increase in flow rate and thus limit the ability to distinguish true from pseudo-severe stenosis. 70 Absence of LV flow reserve during dobutamine SE is observed in approximately one-third of patients and is associated with high operative mortality (6-33%) with surgical AVR. 64, 65 However, this factor does not predict absence of LV function improvement in symptomatic status, and late survival after surgery. 65, 66 Thus, the absence of LV flow reserve should not preclude consideration for surgical or transcatheter AVR. 65 The lack of stroke volume increase during dobutamine SE can result from: (i) afterload mismatch due to an imbalance between the severity of the stenosis and myocardial reserve, (ii) inadequate increase of myocardial blood flow due to associated coronary artery disease, and/or (iii) irreversible myocardial damage due to previous myocardial infarction or extensive myocardial fibrosis. 64 The peak stress values of stroke volume index, LVEF, or longitudinal strain (LV functional reserve) obtained during dobutamine SE may be better than the absolute or relative changes in these parameters because the peak stress values represent a composite measure accounting for both baseline resting LV function and LV functional reserve. [67] [68] [69] Typically in true-severe AS, marked increases in gradients with small or no increases in AVA are observed during dobutamine SE, whereas in pseudo-severe AS, gradients increase only slightly or do not change and the AVA increases significantly with dobutamine SE.The most important parameters and criteria to identify true-severe AS during dobutamine SE are: a mean pressure gradient ≥40 mmHg or peak aortic jet velocity ≥4 m/s with an AVA <1.0 cm 2 . Pseudo-severe AS is generally defined as a peak stress mean pressure gradient <40 mmHg and a peak stress AVA > 1.0 cm 2 . Some studies suggest that the cut-point value of peak stress AVA should be raised from 1.0 to 1.2 cm 2 based on the concept that a moderate-to-severe AS may be well tolerated by a patient with preserved LVEF but may be detrimental for a patient with a depressed LVEF. 69, 70 When the AVA-gradient discordance and thus the uncertainty about actual stenosis severity persist with dobutamine SE (i.e. peak stress gradient <40 mmHg and peak stress AVA < 1.0 cm 2 ), it is helpful to calculate the projected AVA at normal flow rate (Q) (i.e. 250 mL/s) using the formula 4,70,71 :
where AVA rest and Q rest are the AVA and mean transvalvular flow rate measured at rest and ÄAVA and ÄQ are the absolute changes in AVA and Q measured during dobutamine SE.
Patients with pseudo-severe stenosis have no indication for AVR but require optimization of HF therapy and close echocardiographic followup. 22 ,23,72 AVR should be considered in patients with evidence of true-severe AS on dobutamine SE. According to ESC/EACTS and ACC/AHA guidelines, 22, 23 symptomatic patients with classical LF-LG AS and evidence of severe AS on dobutamine SE (Stage D2) have a class IIa, level of evidence C, indication for AVR. 22, 23 However, patients with no LV flow reserve have high operative risk and therefore, the ESC/ EACTS guidelines provided a weaker recommendation (IIb, level of evidence C) for AVR in these patients. Less invasive procedures such as transcatheter AVR could be considered in these patients with no LV flow/functional reserve and evidence of severe AS. 4 
Low-flow, Low-gradient AS with Preserved Ejection Fraction
Paradoxical LF-LG AS is defined as LVEF ≥ 50%, stroke volume index <35 mL/m 2 , an AVA <1.0 cm 2 , indexed AVA < 0.6 cm 2 /m 2 , and mean gradient <40 mmHg at rest. 22, 23 Recent studies 73 suggest that exercise-(in patients with no/mild/ ambiguous symptoms) or low-dose dobutamine-(in symptomatic patients) SE may be useful in patients with paradoxical LF-LG AS to corroborate stenosis severity. The same parameters and criteria as those described for classical LF-LG AS can be applied. About onethird of the patients with paradoxical LF-LG AS have pseudo-severe stenosis, which is similar to what has been reported in patients with classical LF-LG AS. 73 However, dobutamine SE is often not feasible or inconclusive in patients with paradoxical LF-LG AS due to the presence of LV restrictive physiology pattern. If such is the case, aortic valve calcium scoring by multidetector computed tomography may be used to confirm stenosis severity. According to ESC/EACTS and ACC/AHA guidelines, 22, 23 symptomatic patients with paradoxical LF-LG AS and evidence of severe AS (Stage D3) have a class IIa, level of evidence C, indication for AVR.
Multivalvular Heart Disease
Although assessment of multivalvular disease is technically challenging clinically as well as with imaging, SE is well suited for this assessment. Mixed stenotic and regurgitant lesions can be assessed with a combination of colour flow imaging and Doppler, and multiple valves can be systematically assessed during exercise. Limited data, however, exist regarding the assessment and management of patients with multivalvular disease. 22, 74 Evaluation of multivalvular disease with SE is indicated when the patient's symptoms are disproportionate to the resting haemodynamics. 22, 23 In this case, exercise testing can uncover an explanation for symptoms, e.g. the gradient or regurgitation increases or PH develops. When the valve disease is severe but the patient is asymptomatic, exercise testing may uncover an abnormal haemodynamic response, arrhythmia, marked ST-segment shifts, or may demonstrate that the patient is indeed limited by symptoms. 4 Bicycle stress testing is best suited for the evaluation of multivalvular disease, as multiple valves can be assessed during exercise, rather than during recovery 4 .
The strategy for assessment of the valves should be based on the rest echocardiographic images, including a sequence for interrogation of each valve of interest. There is usually one dominant lesion and the strategy of valve interrogation must take this into consideration. It may be necessary to prolong the stages of exercise from 2 or 3 -5 min to complete the indicated colour flow and Doppler assessment. It is valuable to assess haemodynamic changes occurring during the early stages of exercise, especially in patients who are limited by exertional symptoms that may abruptly result in inability to exercise further. 52 Exercise flow augmentation is known to differ for the mitral and aortic valves; the mean mitral orifice area increases with exercise, whereas increases in stroke volume at the level of the aortic valve are mediated by increases in the aortic time velocity integral. Rheumatic mitral valve disease may include both stenosis and regurgitation and the relative importance of these lesions may vary during exercise; recognition of this is important for treatment. Similarly, in aortic valve disease with combined stenosis and regurgitation, the consequences of the combination may be additive. 4 Post Heart Valve Procedures SE is a valuable tool for the evaluation of prosthetic valve haemodynamic function and may be useful when there is discordance between the patient's symptomatic status and the prosthetic valve haemodynamics. In patients with no, mild, or equivocal symptoms, the preferred modality is exercise SE using a protocol with graded bicycle exercise performed in the semi-supine position. 19 Low-dose (up to 20 ìg/kg/min) dobutamine SE is used in patients with moderate or severe symptoms. 4 
Aortic and Mitral Prosthetic Valves
Given that most prosthetic valves with normal function cause some degree of stenosis, the resting values of transprosthetic velocity and gradient overlap considerably between the normally and abnormally functioning prostheses. [76] [77] [78] [79] However, with the increase in flow achieved during exercise or dobutamine SE, patients with significant prosthetic valve stenosis or prosthesis-patient mismatch (PPM) will generally show a marked increase in transprosthetic gradient often accompanied by the development of pulmonary arterial hypertension (PH) and subsequent impaired exercise capacity. On the other hand, patients with normal prosthetic valve function or with a localized high gradient (bileaflet mechanical valves with higher pressure recovery) usually have minimal increase in gradient during SE. 4 stenosis (e.g. calcification, pannus overgrowth) or PPM, especially when there is a concomitant rise in SPAP (>60 mmHg). A potential limitation of SE in this setting is the interference of the prosthetic material with the Doppler signal. This may lead to appearance of spectral Doppler artefacts, therefore, decreasing the accuracy of transprosthetic pressure gradient measurements, especially during exercise. High resting and stress gradients occur more often with smaller (≤21 mm for aortic and ≤25 for mitral) and mismatched prostheses. 4, [80] [81] [82] Mitral Valve Annuloplasty 4, [80] [81] [82] [83] [84] [85] [86] [87] [88] In patients with ischaemic MR, restrictive mitral valve annuloplasty may create some degree of functional MS. This abnormality may also occur in patients with degenerative MR following mitral valve repair, especially when complete ring annuloplasty is used. Some degree of functional MS may occur in up to 50% of patients undergoing mitral valve annuloplasty and this haemodynamic sequel is associated with higher SPAP, worse functional capacity, and poorer quality of life.
Resting Doppler-echocardiographic assessment of mitral valve haemodynamics and SPAP may grossly underestimate the incidence and severity of functional MS following mitral valve annuloplasty because an important proportion of these patients have reduced transmitral flow rate. Indeed, the majority of patients with ischaemic MR have persistent LV systolic dysfunction and thus, LF state after surgery. â-Blocker therapy in these patients lengthens diastole and reduces transvalvular flow rate for a given stroke volume, mitigating the impact of significant functional MS.
Exercise or dobutamine SE may be useful to unmask functional MS in patients who underwent mitral valve repair. This test should be considered in patients with resting mean gradient >3 mmHg who have persistent or recurrent symptoms following surgery. An absolute increase in mean transmitral gradient ≥7 mmHg with concomitant peak exercise SPAP ≥ 50 mmHg suggests the presence of functional MS. 4 Fig.-3 Exercise or dobutamine SE may be helpful in confirming the presence of haemodynamically significant prosthetic valve stenosis or PPM in patients with mildly to moderately elevated transprosthetic gradients at rest: i.e. between 20 and 40 mmHg in the aortic position or 5 10 mmHg in the mitral position. A disproportionate increase in transvalvular gradient (>20 mmHg for aortic prostheses or >10 mmHg for mitral prostheses) generally indicates severe prosthesis 
Summary:
Exercise SE provides information about disease severity and individual outcome in MR. MR severity, SPAP, and left and right ventricular contractile reserve should be evaluated according to the clinical context. An increase by ≥1 grade in MR (from moderate-to-severe MR), an SPAP ≥60 mmHg, and a lack of contractile reserve (<5% increase in EF or <2% increment in global longitudinal strain) are markers of poor prognosis. In AR, SE is used to assess symptoms, exercise tolerance, and the LV response to stress but not the valve disease severity. A lack of contractile reserve is associated with postoperative LV dysfunction. SE is indicated to reveal symptoms and assess haemodynamic consequences of MS-based on the gradient and SPAP increase during stress-in patients with discordance between symptoms and stenosis severity. Exercise SE is preferred for SPAP assessment. MS should be considered severe if exertion results in a mean gradient >15 mmHg and SPAP >60 mmHg. In patients with asymptomatic severe AS, exercise SE may uncover the development of symptoms, necessitating consideration for AVR. The main risk markers are a marked (>18-20 mmHg) increase in mean pressure gradient, a deterioration of LV systolic function, the lack of LV functional reserve, and the development of PH (SPAP>60 mmHg) during exercise. These markers can also be used to adjust the timing of follow-up in patients with moderate AS. In classical low-flow, low-gradient AS with reduced LVEF, a low-dose dobutamine SE is recommended to: (i) assess LV flow reserve, which is helpful for surgical risk stratification and (ii) differentiate true-from pseudo-severe AS, which is key for guiding the decision to perform AVR. In paradoxical low-flow, lowgradient AS with preserved LVEF, exercise or dobutamine SE may also be used to differentiate true-from pseudo-severe AS. In patients with aortic or mitral prosthetic valves and mild-tomoderate elevation of the resting transprosthetic gradients, exercise SE is useful to confirm: (i) the presence of significant prosthetic valve stenosis or PPM, (ii) the symptomatic status. In patients with aortic or mitral prosthetic valves and LF state with small resting EOA or abnormal Doppler velocity index, low-dose dobutamine SE is useful to differentiate true significant prosthesis dysfunction or PPM vs. pseudo-dysfunction. In symptomatic patients with mitral valve annuloplasty and mild increase in resting transmitral gradients, exercise or dobutamine SE is useful to confirm the presence of functional MS.
Conclusion: Stress echocardiography (SE) is increasingly recognized for its utility in the evaluation of valvular heart disease as it is a unique and highly versatile technique. SE allows for simultaneous assessment of myocardial function and haemodynamics under physiological or pharmacological conditions. The versatility of SE is great and expanded use is likely. Due to its diagnostic and prognostic value, SE has become widely implemented to assess various conditions of valvular heart diseases; It has thus become essential to establish guidance for its applications and performance in this area.
